Download PDF
Thromb Haemost 1996; 76(06): 1004-1008
DOI: 10.1055/s-0038-1650700
Original Article
Schattauer GmbH Stuttgart

Isolated Familial Plasminogen Deficiency May not Be a Risk Factor for Thrombosis

R C Tait
The Department of Haematology, Royal Infirmary, Glasgow, Scotland
,
Isobel D Walker
The Department of Haematology, Royal Infirmary, Glasgow, Scotland
,
J A Conkie
The Department of Haematology, Royal Infirmary, Glasgow, Scotland
,
S I A M Islam
1   Glasgow and West of Scotland Blood Transfusion Service, Law Hospital, Carluke, Scotland
,
Frances McCall
The Department of Haematology, Royal Infirmary, Glasgow, Scotland
› Author Affiliations
Further Information

Publication History

Received 19 March 1996

Accepted after resubmission 08 August 1996

Publication Date:
11 July 2018 (online)

Also available at
  PDF Download  Permissions and Reprints

Summary

Despite many reports of individuals with congenital plasminogen deficiency and thrombosis, there is still uncertainty whether heterozygous deficiency represents a real thrombophilic risk factor or simply a coincidental finding. We have addressed this issue by testing for plasminogen deficiency in a cohort of 9611 blood donors. Out of 66 donors with reduced plasminogen activity on two occasions 28 were shown to have a familial deficiency state (including 3 with dysplasminogen-aemia). Our observed prevalence rate for familial plasminogen deficiency, calculated at 2.9/1000 (95% Cl = 1.9-4.2 per 1000), was not significantly different from that calculated from published reports of congenital plasminogen deficiency in thrombotic cohorts (5.4/1000). Furthermore, with only two exceptions, all 80 donors and relatives with familial deficiency were asymptomatic with regard to thrombosis -including a 29 year old donor with suspected compound heterozygous hypoplasminogenaemia. These findings add further weight to the argument that familial heterozygous plasminogen deficiency, at least in isolation, does not constitute a significant thrombotic risk factor. However, it remains uncertain whether plasminogen deficiency, when combined with other thrombophilic conditions, may become more clinically important.

 

  • References

  • 1 Kluft C, Verheijen JH, Engesser L. Fibrinolysis and thrombophilia; an introduction. Fibrinolysis 1988; 2 (Suppl. 02) 1-6
    PubMedGoogle Scholar
  • 2 Bertina RM. Prevalence of hereditary thrombophilia and the identification of genetic risk factors. Fibrinolysis 1988; 2 (Suppl. 02) 7-13
    PubMedGoogle Scholar
  • 3 Lijnen HR, Collen D. Congenital and acquired deficiences of components of the fibrinolytic system and their relation to bleeding or thrombosis. Fibrinolysis 1989; 3: 67-77
    PubMedGoogle Scholar
  • 4 Nilsson IM, Ljungner H, Tengborn L. Two different mechanisms in patients with venous thrombosis and defective fibrinolysis: Low concentration of plasminogen activator or increased concentration of plasminogen activator inhibitor. Br Med J 1985; 290: 1453-1455
    CrossrefPubMedGoogle Scholar
  • 5 Malm J, Laurell M, Nilsson IM, Dahlbäck B. Thromboembolic disease - critical evaluation of laboratory investigations. Thromb Haemost 1992; 68: 7-13
    Article in Thieme ConnectPubMedGoogle Scholar
  • 6 Petaja J, Rasi V, Myllyla G, Hallman V, Hallman H. Familial hypofibrinolysis and venous thrombosis. Br J Haematol 1989; 71: 393-398
    PubMedGoogle Scholar
  • 7 Engesser L, Brommer EJP, Kluft C, Briet E. Elevated plasminogen activator inhibitor (PAI), a cause of thrombophilia? - A study in 203 patients with familial or sporadic venous thrombophilia. Thromb Haemost 1989; 62: 673-680
    Article in Thieme ConnectPubMedGoogle Scholar
  • 8 Patrassi GM, Sartori MT, Saggiorato G, Boeri G, Girolami A. Familial thrombophilia associated with high levels of plasminogen activator inhibitor. Fibrinolysis 1992; 6: 99-103
    PubMedGoogle Scholar
  • 9 Kluft C, Leebeek FWG. Alpha-2-antiplasmin and thrombosis: Results of a questionnaire. Fibrinolysis 1988; 2 (Suppl. 02) 47-48
    PubMedGoogle Scholar
  • 10 Ehrenforth S, Aygoren-Pursun E, Hach-Wunderle V, Scharrer I. Prevalence of elevated histidine-rich glycoprotein in patients with thrombophilia - a study of 695 patients. Thromb Haemost 1994; 71: 160-161
    PubMedGoogle Scholar
  • 11 Aoki N, Moroi M, Sakata Y, Yoshida N, Matsuda M. Abnormal Plasminogen. J Clin Invest 1978; 61: 1186-1195
    CrossrefPubMedGoogle Scholar
  • 12 Hasegawa DK, Tyler BJ, Edson JR. Thrombotic disease in three families with inherited plasminogen deficiency. Blood 1982; 60 (Suppl. 01) 213a
    PubMedGoogle Scholar
  • 13 Kazama M, Tahara C, Suzuki Z, Gohchi K, Abe T. Abnormal Plasminogen, a case of recurrent thrombosis. Thromb Res 1981; 21: 517-522
    CrossrefPubMedGoogle Scholar
  • 14 Soria J, Soria C, Bertrand O, Dunn F, Drouet L, Caen JP. Plasminogen Paris I: Congenital abnormal plasminogen and its incidence in thrombosis. Thromb Res 1983; 32: 229-238
    CrossrefPubMedGoogle Scholar
  • 15 Robbins KC. Classification of abnormal plasminogens: dysplasminogenemias. Semin Thromb Hemost 1990; 16: 217-220
    Article in Thieme ConnectPubMedGoogle Scholar
  • 16 Dolan G, Greaves M, Cooper P, Preston FE. Thrombovascular disease and familial plasminogen deficiency: a report of three kindreds. Br J Haematol 1988; 70: 417-421
    CrossrefPubMedGoogle Scholar
  • 17 Tabemero MD, Sarmiento RG, Tomas JF, Alberca I. Plasminogen deficiency in a Spanish family. Fibrinolysis 1988; 2 (Suppl. 02) 40-42
    PubMedGoogle Scholar
  • 18 Scharrer I, Hach-Wunderle V, Wohl RC, Sinio L, Boreisha I, Robbins KC. Congenital abnormal plasminogen, Frankfurt I, a cause for recurrent venous thrombosis. Haemostasis 1988; 18: 77-86
    PubMedGoogle Scholar
  • 19 Girolami A, Marafioti F, Rubertelli M, Cappellato MG. Congenital heterozygous plasminogen deficiency associated with sever thrombotic tendency. Acta Haematol 1986; 75: 54-57
    CrossrefPubMedGoogle Scholar
  • 20 Mannucci PM, Kluft C, Traas W, Seveso P, D’Angelo A. Congenital plasminogen deficiency associated with venous thromboembolism: therapeutic trial with stanozolol. Br J Haematol 1986; 63: 753-759
    CrossrefPubMedGoogle Scholar
  • 21 Dolan G, Preston FE. Familial plasminogen deficiency and thromboembolism. Fibrinolysis 1988; 2 (Suppl. 02) 26-34
    PubMedGoogle Scholar
  • 22 Sartori MT, Patrassi GM, Theodoridis P, Perin A, Pietrogrande F, Girolami A. Heterozygous type I plasminogen deficiency is associated with increased risk for thrombosis: a stastical analysis in 20 kindreds. Blood Coag Fibrinol 1994; 5: 889-893
    CrossrefPubMedGoogle Scholar
  • 23 Girolami A, Sartori MT, Sgarabotto D, Patrassi GM. Spontaneous versus secondary thrombosis in congenital heterozygous plasminogen deficiency. Thromb Haemost 1993; 69: 530-531
    Article in Thieme ConnectPubMedGoogle Scholar
  • 24 Shigekiyo T, Uno Y, Tomonari A, Satoh K, Hondo H, Ueda S, Saito S. Type I congenital plasminogen deficiency is not a risk factor for thrombosis. Thromb Haemost 1992; 67: 189-192
    Article in Thieme ConnectPubMedGoogle Scholar
  • 25 Bertina RM, Reitsma PH, Rosendaal FR, Vandenbroucke JP. Resistance to activated protein C and Factor V Leiden as risk factors for venous thrombosis. Thromb Haemost 1995; 74: 449-453
    Article in Thieme ConnectPubMedGoogle Scholar
  • 26 Tait RC, Walker ID, Reitsma PH, Islam SIAM, McCall F, Poort SR, Conkie JA, Bertina RM. Prevalence of protein C deficiency in the healthy population. Thromb Haemost 1995; 73: 87-93
    Article in Thieme ConnectPubMedGoogle Scholar
  • 27 Tait RC, Walker ID, Perry DJ, Islam SIAM, Daly ME, McCall F, Conkie JA, Carrell RW. Prevalence of antithrombin deficiency in the healthy population. Br J Haematol 1994; 87: 106-112
    CrossrefPubMedGoogle Scholar
  • 28 Tait RC, Walker ID, Conkie JA, Islam SIAM, McCall F, Mitchell R, Davidson JF. Plasminogen levels in healthy volunteers - influence of age, sex, smoking and oral contraceptives. Thromb Haemost 1992; 68: 506-510
    Article in Thieme ConnectPubMedGoogle Scholar
  • 29 Peterson RA, Krull PE, Finley P, Ettinger MG. Changes in antithrombin III and plasminogen induced by oral contraceptives. Am J Clin Pathol 1970; 53: 468-473
    CrossrefPubMedGoogle Scholar
  • 30 Allaart CF, Poort SR, Rosendaal FR, Reitsma PH, Bertina RM, Briet E. Increased risk of venous thrombosis in carriers of hereditary protein C deficiency defect. Lancet 1993; 341: 134-138
    CrossrefPubMedGoogle Scholar
  • 31 Finazzi G, Caccia R, Barbui T. Different prevalence of thromboembolism in the subtypes of congenital antithrombin III deficiency: Review of 404 cases. Thromb Haemost 1987; 58: 1094
    Article in Thieme ConnectPubMedGoogle Scholar
  • 32 Jespersen J, Kluft C. Decreased levels of histidine-rich glycoprotein (HRG) and increased levels of free plasminogen in women on oral contraceptives low in estrogen. Thromb Haemost 1982; 48: 283-285
    Article in Thieme ConnectPubMedGoogle Scholar
  • 33 Aoki N, Tateno K, Sakata Y. Differences of frequency distributions of plasminogen phenotypes between Japanese and American populations: New methods for detection of plasminogen variants. Biochem Genet 1984; 22: 871-881
    CrossrefPubMedGoogle Scholar
  • 34 Kazama M, Tahara C, Naito I, Nakamura K, Matsuda J, Abe T. Incidence of congenital abnormality of plasminogen in healthy adults and in severe disease. Thromb Haemost 1983; 50: 258a
    PubMedGoogle Scholar
  • 35 Engesser L, Briet E, Dubbeldam J, Kret MJ, Brommer EJP. Disorders of coagulation and fibrinolysis and their association with venous thrombophilia: A study in 203 unrelated patients. In: Thrombophilia - Disorders of blood coagulation and fibrinolysis Engesser L. ed Krips Repro Meppel; 1988: 91-128
  • 36 Briet E, Engesser L, Brommer EJP, Broekmans AW, Bertina RM. Thrombophilia: Its causes and a rough estimate of its prevalence. Thromb Haemost 1987; 58: 39a
    PubMedGoogle Scholar
  • 37 Melissari E, Monte G, Lindo VS, Pemberton KD, Wilson NV, Edmondson R, Das S, Kakkar VV. Congenital thrombophilia among patients with venous thromboembolism. Blood Coag Fibrinol 1992; 3: 749-758
    CrossrefPubMedGoogle Scholar
  • 38 Scharrer I, Hach-Wunderle V, Aygoren E, Lottenberg R, Robbins KC. Frequency and clinical manifestations of congenital plasminogen and fibrinogen deficiency compared to AT III-, PC-, and PS- deficiency in patients suffering from thromboses. Fibrinolysis 1988; 2 (Suppl. 02) 16-17
    PubMedGoogle Scholar
  • 39 Tabemero MD, Thomas JF, Alberca I, Orfao A, Borrasca AL, Vicente V. Incidence and clinical characteristics of hereditary disorders associated with venous thrombosis. Am J Haematol 1991; 36: 249-254
    CrossrefPubMedGoogle Scholar